🚀 Join us for a fireside chat with David Llewellyn on the biotech spinout journey 🧬 Hear from David, co-founder and former CEO of DJS Antibodies (now part of AbbVie), on the DJS journey, lessons learned along the way and candid advice for founders. Sign up below to join us for a thought-provoking and insightful discussion moderated by Michelle He, Investment Manager at Tin Alley Ventures. 📅 Date: 9th of December 2024 🕒 Time: 5pm - 7pm 📌 Melbourne 🔗 https://lnkd.in/gDyNnBUY We look forward to seeing you! #Biotech #FiresideChat #Innovation #Entrepreneurship #Startups #LifeSciences #Unimelb
Tin Alley Ventures
Venture Capital and Private Equity Principals
Carlton, Victoria 716 followers
If you have or want to build a deeptech business in Melbourne reach out | contact@tinalleyventures.com
About us
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses
- Website
-
www.tinalleyventures.com
External link for Tin Alley Ventures
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- Carlton, Victoria
- Type
- Partnership
- Founded
- 2023
Locations
-
Primary
Get directions
700 Swanston St
Carlton, Victoria 3053, AU
Employees at Tin Alley Ventures
-
Ken Jefferd
Managing Director | Research Innovation Commercialisation | UM Commercialistion Pty Ltd
-
Andrew McLean
Managing Partner, Tin Alley Ventures
-
Steve Duke
Founder of The Hemingway Group | ex McKinsey | Mental Health
-
Nina Hooper
Developing and investing in space, climate and AI
Updates
-
We are excited to announce our involvement in the exteRNA seed fundraising round alongside IP Group plc, WEHI Ventures and Hostplus. The company is on an exciting journey to advance their pipeline of small molecule inhibitors targeting RNA processing across a range of tumor types. Congratulations to Vihandha Wickramansinghe, Guillaume Lessene and the entire team for achieving this important milestone. #venturecapital #biotech #australia #RNA
-
Our Managing Partner Andrew McLean spoke to the AFR last week to share why we’re excited to be leading the way for Australian university innovation in deep tech and life sciences. It all comes down to a few key ingredients – first of which is the quality of the science and technology in the University of Melbourne ecosystem, as well as other universities around Australia. For the full recipe, read more here: https://lnkd.in/g3C-eyPU #venturecapital #UniversityofMelbourne #australia #afr
John Wylie is betting venture capital’s business model must change
afr.com
-
We're #hiring a new Intern in Melbourne, Victoria. If you're curious about science and passionate about changing the world please apply!